Mega-dose methylprednisolone (MDMP) for chronic idiopathic myelofibrosis (Author's reply)

References (10)

1. Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C, Chauncey TR, Doney K, Georges GE, Kiem HP, Martin PJ, Petersdorf EW, Radich J, Sanders JE, Sandmaier BM, Warren EH, Witherspoon RP, Storb R, Appelbaum FR. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood. 2003;102:3912-8
2. Rondelli D, Barosi G, Bacigalupo A, Prchal JT, Popat U, Alessandrino EP, Spivak JL, Smith BD, Klingemann HG, Fruchtman S, Hoffman R; Myeloproliferative Diseases- Research Consortium. Blood.2005;105:4115-9
3. Lofvenberg E, Wahlin A,Roos G, Ost A.Reversal of myelofibrosis by hydroxyurea. Eur JA Haematol.1990;44:33-8
4. Faoro LN, Tefferi A, Mesa RA. Long term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia. Eur J Haematol. 2005;74:117-20
5. Barosi G, Hoffman R. Idiopathic myelofibrosis. Semin Hematol.2003; 42:248-58
6. Cervantes f, Hernadez- Boluda JC, Alvarez A, Nadal E, Montserrat E. Danazol treatment of idiopathic myelofibrosis with severe anemia. Haematologica.2000;85-59 5-599
7. Mesa RA, Steensma DP, Pardanani A, Li CY, Elliott M, Kaufmann SH, Wiseman G, Gray LA, Schroeder G, Reeder T, Zeldis JB, Tefferi A. A phase 2 trial of combination low dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia. Blood 2003; 101:2534-41
8. Barosi G, Grossi A, Comotti B, Musto P, Gamba G, Marchetti M. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid mataplasia.Br J Haematol.2001; 114:78-83
9. Tefferi A, Cortes J, Verstovsek S, Mesa RA, Thomas D, Lasho TL, Hogan WJ, Litzow MR, Allred JB, Jones D, Byrne C, Zeldis JB, Ketterling RP, McClure RF, Giles F, Kantarjian HM. Lenalidomide therapy in myelofibrosis with myeloid metaplasia. Blood 2006; 108: 1158-64
10. Hoffman R,Ravandi-Kashandi F. İdiopathic myelofibrozis. In: Hoffman R, Benz EJ Jr, Shattil SJ, et al eds. Hematology: Basic Principles and Practices. 4th edition. Philedelphia, PA: Elsevier Scientific; 2005:1255-1257.